Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Adaptive Biotechnologies Corp (ADPT) vs Constellation Energy Corporation (CEG) Price & Performance

Adaptive Biotechnologies CorpTrade
Constellation Energy CorporationTrade

Price performance (Past 24H)

Key statistics

Adaptive Biotechnologies Corp vs Constellation Energy Corporation — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Constellation Energy Corporation trades at $284.81 (market cap $98.63B). The key difference: Constellation Energy Corporation is far larger — about 24.4× Adaptive Biotechnologies Corp's market cap, and Constellation Energy Corporation pays a 0.61% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.

ADPTCEG
Market Cap
$4.04B$98.63B
Sector
HealthEnergy
52-Week High
$25.45$403.95
52-Week Low
$12.30$236.50
Enterprise Value
$4.10B$122.63B
Dividend Yield
0.61%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Adaptive Biotechnologies Corp

ADPT trades at $25.45, up 2.09% today, near its 52-week high. The stock shows bullish technical signals with support at $25 and resistance at $26. Revenue growth accelerated to $277M in 2025, though net losses persist. Recent news highlights a strategic separation of its MRD and Immune Medicine businesses, aiming to unlock value.

Outlook is cautiously optimistic with 65% analyst buy ratings and a $25.50 price target. Key opportunities include MRD segment profitability and separation benefits, while risks involve sustained losses, competitive pressures, and execution challenges in the business split.

Constellation Energy Corporation

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.

Read more on ADPT

About Constellation Energy Corporation

Constellation is the largest producer of carbon-free energy in the U.S. and a leading nuclear power plant operator. It provides sustainable electricity to millions of residential, public, and industrial customers.

Read more on CEG